EXPO News and Press, Exponent Inc. From 06/19/21

A weekly summary of dividend activity for Dividend Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Challenger Highlights: Week Of June 20

Endava was one of my best bets over the last six months, with a stable upward trend occurring the whole time. While most of this is due to a valuation swing in-line with market growth, the company also had a strong quarter with a raise to guidance. Thus, I will address the recent ...

The bullish case for Exponent continues as of the most recent earnings, although investors are hesitant after the previous three quarters. This has led to a high valuation and lowered share price as a result, but I will point to metrics that show improvements over 2020. I will use...

A weekly summary of dividend activity for Dividend Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Challenger Highlights: Week Of June 6

Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...

I began investing seriously at the end of 2019 and have since begun researching stocks full time. After traversing 2020, I have already learned much about the market and how to move forward. This article will highlight what I believe is close to a well-rounded portfolio for the co...

MENLO PARK, Calif., May 17, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ: EXPO) today announced the hiring of John Doyle, Dr.P.H., as Group Vice President, Health Sciences. Dr. Doyle will lead the firm’s Health Sciences team, which applies deep interdisciplinary expertise to...

This engineering and construction firm has seen steady EPS growth over the past 5+ years, even as revenues remained flat. With managerial optimism about an uptrend in revenues, shareholders stand to benefit. I find this to be a solid company, and worthy of a long-term DRIP style a...

Exponent, Inc. (EXPO) Q1 2021 Earnings Conference Call April 29, 2021, 4:30 PM ET Company Participants Whitney Kukulka - Investor Relations Dr. Catherine Corrigan - President and CEO Rich Schlenker - Executive Vice President and CFO Conference Call Participants Tobey Sommer - Truist Securitie...

Top-rated stocks in our research that also have a strong track record of beating analyst expectations. Stock ideas cutting across most sectors. Over 50 ideas worth considering for watch lists. For further details see: Stocks With The Best History Of Beating Estimates